Description

DL-01 is a drug-linker conjugates for ADC that can be used for the synthesis of ADCs[1].–20°C (Powder, protect from light, stored under nitrogen)-Applications-Cancer-programmed cell death-Formula-C55H71N9O13S-Citation–References-[1]Yonghan Hu, et al. Antibody, antibody-drug conjugate thereof and use thereof. Patent WO2023046202A1.-CASNumber-2821770-49-2-MolecularWeight-1098.27-Compound Purity–SMILES-CS(C1=NC=C(C=N1)C#CCCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN(CCC)CCC)C(NCC(NCOCCCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)(=O)=O-Research_Area-Cancer-Solubility-DMSO : 100 mg/mL (ultrasonic)-Target-Drug-Linker Conjugates for ADC-Isoform–Pathway-Antibody-drug Conjugate/ADC Related-MCE Product type-ADC Related